OUTL news

Latest 1 stories · newest May 29, 2026

OUTL

Outlook Therapeutics prices 8.5M share offering under Form S-3

Outlook Therapeutics completed a public offering of 8,539,709 common shares via Form S-3 registration, with counsel providing legal opinion on share validity. The offering provides capital for the biopharmaceutical company's operations and pipeline development.

Offering May 29, 2026 sentiment +0.50 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same OUTL feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/OUTL/newsSTART FREE